Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Julius

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Atherosclerosis. Supplements|May 5, 2015
Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresisJuergen Graessler, Kai Schuhmann, Andrej Shevchenko, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresisReinhard Klingel, Franz Heigl, Volker Schettler, et al.
Atherosclerosis. Supplements|May 5, 2015
First data from the German Lipoprotein Apheresis Registry (GLAR)Volker J J Schettler, Class L Neumann, Christian Peter, et al.
Circulation|September 24, 2013
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter studyJosef Leebmann, Eberhard Roeseler, Ulrich Julius, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?Franz Heigl, Tobias Pflederer, Reinhard Klingel, et al.
Diabetes Care|March 12, 2008
Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care researchUlrike Rothe, Gabriele Müller, Peter E H Schwarz, et al.
Atherosclerosis. Supplements|November 4, 2017
CaRe high - Cascade screening and registry for high cholesterol in GermanyNina Schmidt, Tanja Grammer, Ioanna Gouni-Berthold, et al.
Investigative Ophthalmology & Visual Science|December 23, 2008
Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic ratsViktor R Drel, Weizheng Xu, Jie Zhang, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 26, 2025
Asymmetric Dimethylarginine: A Never-Aging StoryNatalia Jarzebska, Stefan R Bornstein, Sergey Tselmin, et al.
Atherosclerosis|October 22, 2025
Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-upReinhard Klingel, Ulrich Julius, Wanja M Bernhardt, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Atherosclerosis. Supplements|May 5, 2015
Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresisJuergen Graessler, Kai Schuhmann, Andrej Shevchenko, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresisReinhard Klingel, Franz Heigl, Volker Schettler, et al.
Atherosclerosis. Supplements|May 5, 2015
First data from the German Lipoprotein Apheresis Registry (GLAR)Volker J J Schettler, Class L Neumann, Christian Peter, et al.
Circulation|September 24, 2013
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter studyJosef Leebmann, Eberhard Roeseler, Ulrich Julius, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?Franz Heigl, Tobias Pflederer, Reinhard Klingel, et al.
Diabetes Care|March 12, 2008
Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care researchUlrike Rothe, Gabriele Müller, Peter E H Schwarz, et al.
Atherosclerosis. Supplements|November 4, 2017
CaRe high - Cascade screening and registry for high cholesterol in GermanyNina Schmidt, Tanja Grammer, Ioanna Gouni-Berthold, et al.
Investigative Ophthalmology & Visual Science|December 23, 2008
Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic ratsViktor R Drel, Weizheng Xu, Jie Zhang, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 26, 2025
Asymmetric Dimethylarginine: A Never-Aging StoryNatalia Jarzebska, Stefan R Bornstein, Sergey Tselmin, et al.
Atherosclerosis|October 22, 2025
Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-upReinhard Klingel, Ulrich Julius, Wanja M Bernhardt, et al.
Pageof 8